Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.24.1
Consolidated Balance Sheets - USD ($)
Jan. 31, 2024
Oct. 31, 2023
CURRENT ASSETS    
Cash and Cash Equivalents $ 25,003,984 $ 24,448,841
Accounts Receivable 3,030,988 2,643,461
Inventory 12,768,672 11,685,525
Unbilled Receivables 763,123 894,251
Prepaid Expenses 392,591 181,383
Other Current Assets 813,586 1,034,626
Total Current Assets 42,772,944 40,888,087
FIXED ASSETS    
Property and Equipment, net 6,340,113 6,873,320
OTHER ASSETS    
Goodwill 3,382,108 3,382,108
Intangible Assets, net 496,195 486,615
Deferred Tax Asset 21,582 211,386
Total Other Assets 3,899,885 4,080,109
Total Assets 53,012,942 51,841,516
CURRENT LIABILITIES    
Accounts Payable 1,110,284 1,308,201
Accrued Expenses and Other Current Liabilities 855,977 995,630
Deferred Revenue 786,466 975,537
Total Current Liabilities 2,752,727 3,279,368
LONG TERM LIABILITIES    
Deferred Revenue, less current portion 110,538 133,382
Total Liabilities 2,863,265 3,412,750
Commitments and contingencies
STOCKHOLDERS’ EQUITY    
Common Stock, $.001 par value; 150,000,000 shares authorized, 11,164,483 issued and outstanding as of January 31, 2024 and 11,117,695 shares issued and outstanding as of October 31, 2023 11,165 11,118
Treasury Stock (61,933) (46,300)
Additional Paid-in Capital 63,036,013 62,958,984
Accumulated Other Comprehensive Loss (2,412,969) (3,442,549)
Accumulated Deficit (10,422,599) (11,052,487)
Total Stockholders’ Equity 50,149,677 48,428,766
Total Liabilities and Stockholders’ Equity $ 53,012,942 $ 51,841,516